

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60500</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Strong Association of Polymorphism in SPRED2 Gene with Disease Susceptibility and Clinical Characteristics of Rheumatoid Arthritis in the Iranian Population</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Pakzad</surname><given-names>Bahram</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Moghadammanesh</surname><given-names>Hamed</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Salesi</surname><given-names>Mansour</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Salehi</surname><given-names>Rasoul</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>2</issue>
      <fpage>170</fpage>
      <lpage>174</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>8</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>10</month>
          <year>2021</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The high heritability of&amp;nbsp;Rheumatoid Arthritis (RA)&amp;nbsp;has been estimated from&amp;nbsp;different studies.&amp;nbsp;Recently, Genome-Wide Association Studies&amp;nbsp;(GWAS) show a large number of Single Nucleotide Polymorphisms (SNPs) loci affecting susceptibility to RA. The rs934734 polymorphism in the &lt;em&gt;SPRED2&lt;/em&gt; gene is one of these loci. Studies have shown that the &lt;em&gt;SPRED2&lt;/em&gt; gene is involved in the regulation of inflammatory response, leukocyte infiltration, and local chemokine production. In the current study, the possible association between SNP rs934734 (intronic variant) in the &lt;em&gt;SPRED2&lt;/em&gt; gene with RA risk in the Iranian population was evaluated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; One hundred fourteen RA patients and 120 healthy counterparts were recruited in this case-control study to evaluate rs934734 genotypes using the real-time PCR High Resolution Melting method (HRM).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Logistic regression analysis demonstrated that GG and AG genotypes compared with AA genotype increase the risk of RA (GG &lt;em&gt;vs&lt;/em&gt;. AA; OR=4.61; 95%CI [2.21-9.35]; p&amp;lt;0.001 and AG &lt;em&gt;vs&lt;/em&gt;. AA; OR=2.54; 95%CI [1.36-4.76]; p=0.004). Furthermore, subjects with allele G were more frequently affected with RA than subjects with A allele (OR=2.33; 95%CI [1.61-3.38];&lt;em&gt; &lt;/em&gt;p&amp;lt;&lt;span style=&quot;background-color:white&quot;&gt;0.001&lt;/span&gt;). Besides, in the patient group, there was a significant correlation between &lt;span style=&quot;background-color:white&quot;&gt;Erythrocyte Sedimentation Rate (ESR) and C-reactive protein (CRP) &lt;/span&gt;concentration with rs934734 polymorphism (p&amp;lt;0.05).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Our findings suggest that rs934734 in &lt;em&gt;SPRED2&lt;/em&gt; strongly underlies RA development and is associated with clinicopathological characteristics of this disease. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
